May 1, 2024- To advocate for the value of distribution in the healthcare ecosystem, the Health Industry Distributors Association (HIDA) regularly meets and holds annual conferences to bring industry leaders from across the spectrum of healthcare together to share, learn and plan for the future.
“The unique needs of the laboratory industry are brought to the forefront of the conversation along with other key elements of the healthcare supply chain,” said HIDA Board Member Emily Berlin, Vice President Laboratory Marketing & Aero-Med Commercial Sales and Operations, Cardinal Health.
As one of the largest healthcare distributors in the United States, Cardinal Health™ has decades of experience helping lab customers improve their supply chain resiliency and operate more efficiently through a dedication to deliver quality products, value-adding services and reliable supply chain solutions.
“While those of us that are entrenched within distribution understand the fundamental role that distributors play to both large health systems as well as small independent practices, it wasn’t until the pandemic that the true importance of distribution was more broadly understood,” Berlin said.
While the effects of the pandemic have been mitigated to an extent, the major factors impacting clinical laboratories remain consistent: a continuing workforce shortage, decreasing reimbursements, ongoing regulatory legislation and industry consolidation, to name a few. At the same time, diagnostic innovation evolves swiftly, driven by the needs of an aging population, high rates of chronic disease, rapid technological advancements and a greater demand for personalized medicine. The question on the minds of industry leaders remains: How can we best support our lab customers in their pursuit of quality testing amid transformation and constraints?
Read more in the latest issue of JHC.